Blood Res.  2021 Mar;56(1):50-53. 10.5045/br.2021.2020268.

A paradigm shift: lineage switch from T-ALL to B/myeloid MPAL

• Rath A
• Panda T
• Dhawan R
• Dass J
• Mahapatra M
• Viswanathan GK

• KMID: 2514066
• DOI: http://doi.org/10.5045/br.2021.2020268

Abstract

No abstract available

Figure

• 

  Fig. 1 Peripheral blood and bone marrow morphology. Peripheral blood smear showing blasts and monocytes (A). Bone marrow aspirate showing blasts and monocytic population (B). Bone marrow biopsy showing marrow spaces replaced by blasts (C). NSE positivity in blasts (D).

• 

  Fig. 2 Flow cytometric immunophenotyping plots. Flow cytometric immunophenotyping identified two abnormal populations, i.e., B-lymphoblasts (red) and monoblasts/promonocytes (blue), indicating B/myeloid MPAL.

Reference

1. Rossi JG, Bernasconi AR, Alonso CN, et al. 2012; Lineage switch in childhood acute leukemia: an unusual event with poor outcome. Am J Hematol. 87:890–7. DOI: 10.1002/ajh.23266. PMID: 22685031.

2. Wu B, Jug R, Luedke C, et al. 2017; Lineage switch between B-lymphoblastic leukemia and acute myeloid leukemia intermediated by "occult" myelodysplastic neoplasm: two cases of adult patients with evidence of genomic instability and clonal selection by chemotherapy. Am J Clin Pathol. 148:136–47. DOI: 10.1093/ajcp/aqx055. PMID: 28898985.

3. Dorantes-Acosta E, Pelayo R. 2012; Lineage switching in acute leukemias: a consequence of stem cell plasticity? Bone Marrow Res. 2012:406796. DOI: 10.1155/2012/406796. PMID: 22852088. PMCID: PMC3407598.

4. Charles NJ, Boyer DF. 2017; Mixed-phenotype acute leukemia: diagnostic criteria and pitfalls. Arch Pathol Lab Med. 141:1462–8. DOI: 10.5858/arpa.2017-0218-RA. PMID: 29072953.

5. Sakaki H, Kanegane H, Nomura K, et al. 2009; Early lineage switch in an infant acute lymphoblastic leukemia. Int J Hematol. 90:653–5. DOI: 10.1007/s12185-009-0446-7. PMID: 19936875.

6. Heidenreich O, Tirtakusuma R, Bomken S, et al. 2013; The genomic landscape of lineage switch acute leukemia. Blood (ASH Annual Meeting Abstracts). 122(Suppl):2552. DOI: 10.1182/blood.V122.21.2552.2552.

7. Jiang JG, Roman E, Nandula SV, Murty VV, Bhagat G, Alobeid B. 2005; Congenital MLL-positive B-cell acute lymphoblastic leukemia (B-ALL) switched lineage at relapse to acute myelocytic leukemia (AML) with persistent t(4;11) and t(1;6) translocations and JH gene rearrangement. Leuk Lymphoma. 46:1223–7. DOI: 10.1080/10428190500086055. PMID: 16085566.

8. Ruiz-Delgado GJ, Nuñez-Cortez AK, Olivares-Gazca JC, Fortiz YC, Ruiz-Argüelles A, Ruiz-Argüelles GJ. 2017; Lineage switch from acute lymphoblastic leukemia to myeloid leukemia. Med Univ. 19:27–31. DOI: 10.1016/j.rmu.2017.02.001.

9. Aujla A, Hanmantgad M, Islam H, Shakil F, Liu D, Seiter K. 2019; Lineage switch from T-cell lymphoblastic leukemia/lymphoma to acute myeloid leukemia and back to T-cell lymphoblastic leukemia/lymphoma in a patient diagnosed during pregnancy. Stem Cell Investig. 6:12. DOI: 10.21037/sci.2019.05.02. PMID: 31231669. PMCID: PMC6556683.

10. Ittel A, Jeandidier E, Helias C, et al. 2013; First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia. Haematologica. 98:e166–8. DOI: 10.3324/haematol.2013.096750. PMID: 24323992. PMCID: PMC3856982.

11. Higuchi Y, Tokunaga K, Watanabe Y, et al. 2016; Lineage switch with t(6;11)(q27;q23) from T-cell lymphoblastic lymphoma to acute monoblastic leukemia at relapse. Cancer Genet. 209:267–71. DOI: 10.1016/j.cancergen.2016.05.070. PMID: 27268298.

12. Babić A, Kurić L, Dubravčić K, et al. 2020; A case of an unusual lineage switch in late relapse ALL-is it actually a secondary leukemia? J Hematop. 13:51–5. DOI: 10.1007/s12308-019-00371-x.

13. Ganser A, Heuser M. 2017; Therapy-related myeloid neoplasms. Curr Opin Hematol. 24:152–8. DOI: 10.1097/MOH.0000000000000316. PMID: 27930389.

14. McNerney ME, Godley LA, Le Beau MM. 2017; Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer. 17:513–27. DOI: 10.1038/nrc.2017.60. PMID: 28835720. PMCID: PMC5946699.

15. Ganzel C, Devlin S, Douer D, Rowe JM, Stein EM, Tallman MS. 2015; Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy. Br J Haematol. 170:50–5. DOI: 10.1111/bjh.13386. PMID: 25823602.